Delcath Systems Inc. (NASDAQ:DCTH)’s share price was up 47.6% on Thursday . The company traded as high as $5.83 and last traded at $5.83, with a volume of 154,265 shares changing hands. The stock had previously closed at $3.95.

The firm’s 50-day moving average price is $3.99 and its 200 day moving average price is $4.63. The firm’s market capitalization is $6.95 million.

Delcath Systems (NASDAQ:DCTH) last posted its earnings results on Wednesday, May 4th. The medical device company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.11. On average, analysts expect that Delcath Systems Inc. will post ($7.84) EPS for the current fiscal year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.